bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2019: M A M F J
2018: D N O S A J J M

 
  Other news for:
Impotence
Sex
 Resources from HONselect
Guys, Avoid 'Rhino' Sexual Enhancement Products, FDA Says

By Robert Preidt

TUESDAY, Nov. 27, 2018 (HealthDay News) -- The U.S. Food and Drug Administration is warning men that "Rhino" products promising better sex may pose serious health risks.

Since 2007, the FDA has identified more than 25 products marketed with variations of the name Rhino that contained hidden drug ingredients, the agency reported Tuesday.

The FDA has received reports of chest pain, severe headaches and prolonged erections after taking a Rhino male enhancement product. Some men have been hospitalized due to extreme drops in blood pressure.

"Over the past few years, the FDA has been combating the retail sale of male enhancement drug products that are frequently misrepresented as dietary supplements and that contain hidden and potentially harmful active drug ingredients," said Donald Ashley in an agency news release. He's the compliance director in the FDA's Center for Drug Evaluation and Research.

The unapproved products are sold at gas stations and convenience stores, on websites such as eBay and Amazon, and have been found in international mail shipments to the United States.

They are marketed under names such as Platinum Rhino 25000, Krazzy Rhino 25000 and Gold Rhino 25000, and are often sold in single-serving package sizes.

The FDA said Rhino products contain undeclared ingredients that are the same as or structurally similar to active ingredients in prescription drugs used to treat erectile dysfunction.

For example, some contain sildenafil and/or tadalafil, the active ingredients in the prescription drugs Viagra and Cialis, respectively. These undeclared ingredients are phosphodiesterase type-5 (PDE-5) inhibitors, which can pose significant health risks, the agency said.

When these ingredients interact with nitrates found in some prescription drugs, they can cause dangerously low blood pressure. People with diabetes, high blood pressure, high cholesterol or heart disease often take nitrates.

"Distributing unapproved drugs, disguised as supplements, places the U.S. public health at risk," Ashley noted.

If you use any product marketed as a dietary supplement, talk to your health care practitioner about possible interactions with medications or other supplements you take, the FDA advised.

Product claims that sound too good to be true likely are. Search for information about a product on noncommercial sites instead of relying on information provided by sellers, the agency recommended.

More information

The FDA has more on unapproved male sexual enhancement products.

SOURCE: U.S. Food and Drug Administration, news release, Nov. 27, 2018

Copyright © 2018 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=740011

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Specialty Chemicals and Products
Blood
Risk
Nitrates
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact